Reguchole 10/5 Mg, Reguchole 10/10 Mg, Reguchole 10/20 Mg 5 mg, 10 mg, 20 mg Tablet
PDF Leaflet Revision Date: 08 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunctive therapy for hypercholesterolaemia and cardiovascular event prevention.
Dosage (summary)
1 tablet daily; starting dose 10 mg rosuvastatin + 10 mg ezetimibe.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Gemfibrozil
- Ciclosporin
- Protease inhibitors
Contraindications
- Hypersensitivity
- Pregnancy
- Lactation
- Severe renal impairment
- Active liver disease
Common side effects
- Myalgia
- Headache
- Dizziness
- Abdominal pain
- Nausea
Counselling Points
- Monitor for muscle pain or weakness
- Avoid alcohol
- Regular liver function tests recommended
Serious warnings
- Risk of myopathy/rhabdomyolysis
- Liver enzyme elevations
Important Disclaimer
The Reguchole 10/5 Mg, Reguchole 10/10 Mg, Reguchole 10/20 Mg 5 mg, 10 mg, 20 mg Tablet professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
